Boston-based digital surgery company Zeta Surgical announced on Wednesday that its Zeta Navigation System has received 510(k) clearance from the US Food and Drug Administration (FDA) for use with expanded instruments and enhanced hospital connectivity.
The Zeta Surgical platform is designed to provide rapidly deployable, high-accuracy navigation for neurological interventions currently unsupported by existing navigation systems. Its guidance system uses mixed reality and advanced motion-aware remote sensing to enable real-time patient tracking, providing access to navigation across a wide range of neurological interventions.
This latest FDA approval enables the Zeta system to be deployed with a variety of new accessories and surgical kits, including instruments from IZI Medical. It will also allow hospitals to integrate the system's software into their IT networks, allowing for seamless and fast access to patient data.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval